BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 38083894)

  • 1. Improving ADMET Prediction Accuracy for Candidate Drugs: Factors to Consider in QSPR Modeling Approaches.
    Chen M; Yang J; Tang C; Lu X; Wei Z; Liu Y; Yu P; Li H
    Curr Top Med Chem; 2024; 24(3):222-242. PubMed ID: 38083894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictions of the ADMET properties of candidate drug molecules utilizing different QSAR/QSPR modelling approaches.
    Khan MT
    Curr Drug Metab; 2010 May; 11(4):285-95. PubMed ID: 20450477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive QSAR modeling for the successful predictions of the ADMET properties of candidate drug molecules.
    Khan MT; Sylte I
    Curr Drug Discov Technol; 2007 Oct; 4(3):141-9. PubMed ID: 17985997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. General theory for multiple input-output perturbations in complex molecular systems. 1. Linear QSPR electronegativity models in physical, organic, and medicinal chemistry.
    González-Díaz H; Arrasate S; Gómez-SanJuan A; Sotomayor N; Lete E; Besada-Porto L; Ruso JM
    Curr Top Med Chem; 2013; 13(14):1713-41. PubMed ID: 23889050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Partial least square and hierarchical clustering in ADMET modeling: prediction of blood-brain barrier permeation of α-adrenergic and imidazoline receptor ligands.
    Nikolic K; Filipic S; Smoliński A; Kaliszan R; Agbaba D
    J Pharm Pharm Sci; 2013; 16(4):622-47. PubMed ID: 24210068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. QSPR models for the prediction of apparent volume of distribution.
    Ghafourian T; Barzegar-Jalali M; Dastmalchi S; Khavari-Khorasani T; Hakimiha N; Nokhodchi A
    Int J Pharm; 2006 Aug; 319(1-2):82-97. PubMed ID: 16698204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicting binding affinities of diverse pharmaceutical chemicals to human serum plasma proteins using QSPR modelling approaches.
    Basant N; Gupta S; Singh KP
    SAR QSAR Environ Res; 2016; 27(1):67-85. PubMed ID: 26854728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. QSPR studies on aqueous solubilities of drug-like compounds.
    Duchowicz PR; Castro EA
    Int J Mol Sci; 2009 Jun; 10(6):2558-2577. PubMed ID: 19582218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New QSPR study for the prediction of aqueous solubility of drug-like compounds.
    Duchowicz PR; Talevi A; Bruno-Blanch LE; Castro EA
    Bioorg Med Chem; 2008 Sep; 16(17):7944-55. PubMed ID: 18701302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of drug disposition on the basis of its chemical structure.
    Stepensky D
    Clin Pharmacokinet; 2013 Jun; 52(6):415-31. PubMed ID: 23463353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Matrix trace operators: from spectral moments of molecular graphs and complex networks to perturbations in synthetic reactions, micelle nanoparticles, and drug ADME processes.
    Gonzalez-Diaz H; Arrasate S; Juan AG; Sotomayor N; Lete E; Speck-Planche A; Ruso JM; Luan F; Cordeiro MN
    Curr Drug Metab; 2014; 15(4):470-88. PubMed ID: 25204825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Computational modeling of human oral bioavailability: what will be next?
    Cabrera-Pérez MÁ; Pham-The H
    Expert Opin Drug Discov; 2018 Jun; 13(6):509-521. PubMed ID: 29663836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modeling ADMET.
    Ghosh J; Lawless MS; Waldman M; Gombar V; Fraczkiewicz R
    Methods Mol Biol; 2016; 1425():63-83. PubMed ID: 27311462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of blood-brain barrier permeation of α-adrenergic and imidazoline receptor ligands using PAMPA technique and quantitative-structure permeability relationship analysis.
    Vucicevic J; Nikolic K; Dobričić V; Agbaba D
    Eur J Pharm Sci; 2015 Feb; 68():94-105. PubMed ID: 25542610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toward in silico structure-based ADMET prediction in drug discovery.
    Moroy G; Martiny VY; Vayer P; Villoutreix BO; Miteva MA
    Drug Discov Today; 2012 Jan; 17(1-2):44-55. PubMed ID: 22056716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent developments of in silico predictions of intestinal absorption and oral bioavailability.
    Hou T; Li Y; Zhang W; Wang J
    Comb Chem High Throughput Screen; 2009 Jun; 12(5):497-506. PubMed ID: 19519329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent uses of topological indices in the development of in silico ADMET models.
    Votano JR
    Curr Opin Drug Discov Devel; 2005 Jan; 8(1):32-7. PubMed ID: 15679169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An evaluation of mathematical models for predicting skin permeability.
    Lian G; Chen L; Han L
    J Pharm Sci; 2008 Jan; 97(1):584-98. PubMed ID: 17722002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DemQSAR: predicting human volume of distribution and clearance of drugs.
    Demir-Kavuk O; Bentzien J; Muegge I; Knapp EW
    J Comput Aided Mol Des; 2011 Dec; 25(12):1121-33. PubMed ID: 22101402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The application of in silico drug-likeness predictions in pharmaceutical research.
    Tian S; Wang J; Li Y; Li D; Xu L; Hou T
    Adv Drug Deliv Rev; 2015 Jun; 86():2-10. PubMed ID: 25666163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.